Guidline to transfuse albumin in pallitive care

Reading File
Finding Sources
Searching PubMed

albumin infusion palliative care guidelines

Searching the Web

albumin transfusion guidelines palliative care hypoalbuminemia 2024

Finding Sources
Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC11317816

Searching PubMed

albumin hypoalbuminemia palliative care end of life

Here is a practical, evidence-based guide to albumin infusion in palliative care, anchored to the most current major guideline available - the ICTMG 2024 Guideline on Intravenous Albumin (published in CHEST 2024; Callum J et al.).

Albumin Transfusion in Palliative Care: Clinical Guidelines

Background: Why Hypoalbuminemia Occurs in Palliative Patients

In advanced illness, low serum albumin is almost always caused by:
  • Chronic inflammation (IL-6, TNF-alpha suppress hepatic synthesis)
  • Cancer cachexia and malnutrition
  • Third-spacing from liver/renal failure or malignancy
  • Reduced oral intake
Infusing albumin does not correct the underlying cause. The albumin is rapidly redistributed or catabolized, and levels do not stay elevated. This is the central reason guidelines discourage routine use in this population.

The Key Principle

Albumin should NOT be given merely to "correct" a low serum albumin level in palliative or advanced-illness patients. Hypoalbuminemia in this context is a marker of disease severity, not a treatable deficiency.

Evidence-Based Indications (Where Albumin MAY Be Given)

The following are the only settings where evidence supports albumin use - these apply even in patients who also have a palliative diagnosis:
Clinical ScenarioRecommendationEvidence
Cirrhosis + Large Volume Paracentesis (>5 L)For (Conditional)6-8 g albumin per litre of fluid removed, using 20-25% albumin - prevents paracentesis-induced circulatory dysfunction
Cirrhosis + Spontaneous Bacterial Peritonitis (SBP)For (Conditional)Reduces mortality and prevents hepatorenal syndrome
Hepatorenal Syndrome (HRS) Type 1For (Conditional)Combined with vasoconstrictors (e.g. terlipressin)
These indications remain valid even in palliative/end-of-life liver disease patients, provided the intervention aligns with the patient's goals of care.

Where Albumin is NOT Recommended

Clinical ScenarioICTMG 2024 Recommendation
Hypoalbuminemia (serum albumin <30 g/L) alone - cancer cachexia, malnutritionAgainst (Conditional)
Critically ill patients - volume resuscitation or to raise albumin levelAgainst (Conditional)
Hospitalized decompensated cirrhosis with hypoalbuminemia, to raise level >30 g/LAgainst (Conditional)
Cirrhosis + uncomplicated ascites (outpatient)Against (Conditional)
Cirrhosis + extraperitoneal infectionsAgainst (Conditional)
Refractory edema or fluid removal (in conjunction with diuretics)Against (Conditional)
Pediatric patients with sepsis/hypoperfusionAgainst (Strong)
Burns, ARDS - volume replacementAgainst (Conditional)

Palliative Care-Specific Considerations

1. Goals of Care Come First Before any albumin infusion, the clinical team should ask: will this intervention reduce a symptom that matters to the patient (e.g. tense ascites causing breathlessness)? If not, infusion should not proceed regardless of the albumin level.
2. Refractory Ascites
  • Large-volume paracentesis with albumin replacement (6-8 g/L removed) is the standard of care and is appropriate even in palliative patients for symptom relief.
  • Albumin given for ascites without paracentesis to "maintain oncotic pressure" is not supported.
3. Do Not Use Albumin as Nutritional Support Albumin is not a nutrient. It does not provide calories or amino acids. Parenteral nutrition is the appropriate intervention if nutritional support is a goal.
4. Fluid Overload Risk Albumin infusion can worsen pulmonary edema and pleural effusions - common and distressing symptoms in palliative patients. The ATTIRE trial found more severe adverse events (including pulmonary edema) in patients treated with albumin targeting >30 g/L.
5. End-of-Life Phase (Days to Hours) Albumin infusion is generally not appropriate in the final days of life. It does not improve comfort, and IV access/infusion adds burden to dying patients.

Practical Summary

SituationAction
Low albumin on blood test onlyDo NOT transfuse
Tense/symptomatic ascites + cirrhosis, paracentesis plannedGive albumin (20-25%, 6-8 g/L drained)
SBP in cirrhotic palliative patientGive albumin (1.5 g/kg Day 1, 1 g/kg Day 3)
Edema, cachexia, cancer-related hypoalbuminemiaDo NOT transfuse
Patient in last days/hours of lifeDo NOT transfuse
Goals of care discussion pendingDefer until goals clarified

Key Reference

The current authoritative source is: Callum J et al. "Use of intravenous albumin: a guideline from the International Collaboration for Transfusion Medicine Guidelines." CHEST 2024;166(2):321-338. This is the most comprehensive and up-to-date guideline as of 2025-2026, covering 14 clinical scenarios with graded recommendations.
There is no dedicated palliative-care-specific albumin guideline in the literature - the ICTMG 2024 guideline is applied to palliative contexts through the goals-of-care framework described above.

NHA guidlines of albumin transufusion

Searching the Web

NHA National Health Authority India albumin transfusion guidelines

Searching the Web

NHA India albumin infusion clinical guidelines indications 2023 2024

Searching the Web

NHA India "National Health Authority" albumin blood products guidelines pdf

Searching the Web

NABH NHA India albumin clinical use guidelines hospital protocol

Important clarification: There is no publicly available document from India's National Health Authority (NHA) specifically titled "albumin transfusion guidelines." The NHA primarily governs Ayushman Bharat/PMJAY health insurance packages and does not publish standalone clinical transfusion protocols. No such NHA-specific albumin guideline was found in any search.
You may be referring to one of these instead:

What You May Be Looking For

1. Could you mean the National Blood Transfusion Council (NBTC) / CDSCO India guidelines?

India's regulatory body for blood products is the CDSCO (Central Drugs Standard Control Organisation) under the Ministry of Health, with the NBTC guiding clinical use. Their framework follows WHO standards and is incorporated in the Drugs and Cosmetics Act blood bank guidelines.

2. Could you mean NHA's clinical package definitions under Ayushman Bharat?

Under PMJAY, albumin infusion is covered as part of specific treatment packages (e.g., liver disease, sepsis management), but the clinical indications are deferred to standard medical guidelines, not separately defined by NHA.

3. Could you mean a hospital/state authority called "NHA"?

Some regional hospital authorities use "NHA" as an acronym. For example, the pch-pathlab.com document (from a hospital named Perth Children's Hospital) has an albumin guideline - but that is Australian, not Indian.

Most Likely Match: Standard Indian Clinical Practice (NBTC/WHO Framework)

Indian hospitals and medical colleges follow the WHO/NBTC framework for albumin use, which aligns closely with international consensus. The key principles applied in Indian tertiary care are:
IndicationUseNotes
Large-volume paracentesis (cirrhosis, >5L)Yes6-8 g per litre removed (20-25% albumin)
Spontaneous bacterial peritonitis (SBP)Yes1.5 g/kg Day 1, 1 g/kg Day 3
Hepatorenal syndrome (with vasoconstrictors)YesCombined with terlipressin
Hypoalbuminemia alone (any cause)NoNot indicated
Nutritional support / malnutritionNoNot a nutritional agent
General volume resuscitationNoCrystalloids preferred
Palliative / end-of-life hypoalbuminemiaNoNot evidence-based

My Recommendation

Could you clarify what "NHA" refers to in your context? For example:
  • National Health Authority of India (Ayushman Bharat regulator)?
  • A specific hospital or state authority?
  • NHS (UK National Health Service) guidelines? (A common confusion in Indian medical education)
If you mean NHS (UK) guidelines, I can provide those directly - they are detailed, publicly available, and widely referenced in Indian postgraduate training. Just confirm and I'll retrieve the full NHS albumin guideline for you.

Find NHS UK albumin guidelines (widely used in Indian medical education)

Searching the Web

NHS UK human albumin solution guidelines indications clinical use 2023 2024

Searching the Web

NHS England NICE albumin infusion guidelines indications contraindications pdf

Reading Web Page

https://www.nn.nhs.scot/hats/wp-content/uploads/sites/12/202…

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC2719274

Here is a comprehensive summary of NHS UK Human Albumin Solution (HAS) Guidelines, drawing from the NHS Scotland National Plasma Products Expert Advisory Group (NPPEAG) clinical guidelines and the NHS Hospital Transfusion Committee guidelines - the two most authoritative NHS sources on this topic.

NHS UK Guidelines: Human Albumin Solution (HAS)


Available Formulations

FormulationConcentrationVolumeUse
Isotonic HAS4.5% or 5%100-500 mLPlasma volume replacement (burns, trauma, pancreatitis, plasma exchange)
Concentrated HAS20%100 mLLiver disease, SBP, HRS, ascites drainage, nephrotic syndrome

APPROPRIATE INDICATIONS (Evidence-Based)

1. Large Volume Paracentesis (LVP) - Cirrhotic Ascites

The single strongest indication
  • HAS is mandatory following drainage of >5 litres of ascitic fluid in cirrhosis to prevent post-paracentesis circulatory dysfunction (PPCD)
  • Paracentesis without albumin causes a fall in pulmonary capillary wedge pressure (maximal at 6 hours) leading to circulatory and renal dysfunction
Dosing:
  • Normal renal function: HAS 20% - 1 bottle (100 mL = 20 g) per every 3 litres drained
  • Impaired renal function: HAS 20% - 1 bottle per every 2 litres drained
  • Authorised by: Junior medical staff on advice of Gastroenterologist/ITU Consultant

2. Spontaneous Bacterial Peritonitis (SBP)

Albumin reduces incidence of renal failure and mortality in SBP (reduces renin-aldosterone activation)
Dosing:
DayHAS 20%HAS 5%
Day 11.5 g/kg (usually 4-8 bottles of 100 mL)1.5 g/kg (usually 3-6 bottles of 500 mL)
Day 31 g/kg (usually 2-5 bottles)1 g/kg (usually 2-4 bottles)
  • Authorised by: Consultant Gastroenterologist or ITU Consultant

3. Hepatorenal Syndrome (HRS)

Used in combination with Glypressin (terlipressin) - vasopressin analogue
Dosing:
  • HAS 20%: 1 g/kg/day (maximum 100 g/day) for 2+ days
  • Continue daily (1-2 bottles/day) for up to 16 days, or until renal function improves
  • Either 4.5% or 20% may be used depending on fluid status
  • Authorised by: Consultant Gastroenterologist or ITU Consultant

4. Nephrotic Syndrome

  • Short-term use in combination with diuretics for acute severe peripheral/pulmonary oedema
  • Long-term albumin supplementation in nephrotic syndrome is NOT appropriate

5. Severe Burns (after first 24 hours)

  • Burns resuscitation after the first 24 hours
  • NOT before 24 hours - use before this time causes paradoxical pulmonary oedema
  • Replaces subacute plasma volume loss

6. Therapeutic/Plasma Apheresis

  • HAS 5%: 1-1.5 plasma volumes daily
  • For large-volume exchanges (>20 mL/kg/session)
  • Authorised by: Consultant Haematologist

7. Acute Liver Injury

  • To support plasma oncotic pressure
  • Binds excessive bilirubin, activated plasmin, and toxins
  • Used in exchange transfusion in neonates (unconjugated bilirubinaemia)

8. ARDS (selective use)

  • Only when diuretic use has caused a fall in effective plasma volume
  • Not for routine volume resuscitation in ARDS

9. Renal Dialysis

  • Only if the patient becomes hypotensive during dialysis
  • Not routine

10. Critical Care (ICU/HDU)

  • Low serum albumin in a haemodynamically unstable patient
  • HAS 20% may occasionally be indicated
  • Must be requested by Consultant Anaesthetist/Intensivist in ITU/HDU only

INAPPROPRIATE INDICATIONS (NHS Explicitly Lists These as NOT Appropriate)

ConditionReason
Intravascular volume expansion after trauma or major surgeryCrystalloids/colloids preferred
As part of Total Parenteral Nutrition (TPN)Not a nutritional agent
Long-term albumin supplementation in nephrotic syndromeNo benefit shown
Low serum albumin without ascites, SBP, or HRS"Not usually indicated" - refer to Pharmacist
Hypoalbuminaemia >2.5 g/dLNot indicated
Chronic hypoalbuminaemia without oedema or hypotensionNot indicated
Malnutrition / cachexiaNot a nutrient
Wound healingNo evidence
Ascites responsive to diureticsDiuretics sufficient
Burns in first 24 hoursCauses pulmonary oedema
Protein-losing enteropathy / malabsorptionNot indicated
Acute/chronic pancreatitisNo evidence
Cerebral ischaemiaNo evidence
Normovolaemic haemodilution in surgeryNot appropriate
Palliative hypoalbuminaemia (cancer cachexia, malnutrition)Not indicated

Contraindications

  1. Hypersensitivity to albumin or any excipients (absolute)
  2. Conditions where hypervolaemia is dangerous:
    • Cardiac failure
    • Severe hypertension
    • Oesophageal varices
    • Pulmonary oedema
    • Haemorrhagic diathesis
    • Severe anaemia
    • Renal failure with no dialysis access

Administration (NHS Protocol)

ParameterGuidance
RouteIV only
Giving set15-micron filtered, vented giving set required
Rate 4.5/5%Should not exceed 5 mL/min
Rate 20%Should not exceed 2 mL/min
TemperatureWarm to room/body temperature before use
Appearance checkDo NOT use if cloudy or contains deposits
ConsentWritten informed consent required (it is a human blood product)
Jehovah's WitnessesCheck - some refuse all blood products including albumin

Monitoring During Infusion

  • Blood pressure and heart rate
  • Central venous pressure (CVP) or pulmonary artery wedge pressure
  • Urine output
  • Electrolytes, haemoglobin, haematocrit
  • Continuous cardiorespiratory observations

NHS Position on Palliative Care Specifically

The NHS guideline is clear:
"Low serum albumin in the absence of ascites, SBP, or hepatorenal syndrome - NOT usually indicated. Refer request to duty Pharmacist."
This means even in palliative patients with cirrhosis, albumin is only appropriate when one of the three specific complications (LVP, SBP, HRS) is present - not simply to "correct" the albumin level or for comfort alone.

Quick Reference Summary Card

GIVE ALBUMIN (NHS approved):
✅ LVP >5L in cirrhosis → 20% HAS, 1 bottle per 3L drained
✅ SBP → 1.5 g/kg Day 1, 1 g/kg Day 3
✅ Hepatorenal syndrome + terlipressin → 1 g/kg/day (max 100 g)
✅ Nephrotic syndrome (acute, with diuretics)
✅ Burns after 24 hours
✅ Plasma exchange (large volume)
✅ Acute liver injury (oncotic support)

DO NOT GIVE ALBUMIN (NHS):
❌ Low albumin alone (any cause)
❌ Malnutrition / cachexia / TPN
❌ Palliative hypoalbuminaemia
❌ Major surgery / trauma volume replacement
❌ Burns in first 24 hours
❌ Ascites controlled by diuretics
This is a shared conversation. Sign in to Orris to start your own chat.